BIT 0.00% 3.3¢ biotron limited

Ann: Shareholder Update , page-15

  1. 409 Posts.
    lightbulb Created with Sketch. 4
    the alternative interpretation of course, is that no Big Pharma has been interested in the results thus far, and that more drug needs production for use in further trials. The company will not survive without a partnership (or buy-out) so it's important to get those trials underway ASAP.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.